Lymphoma, Non-Hodgkin
"Lymphoma, Non-Hodgkin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.
Descriptor ID |
D008228
|
MeSH Number(s) |
C04.557.386.480 C15.604.515.569.480 C20.683.515.761.480
|
Concept/Terms |
Lymphoma, Non-Hodgkin- Lymphoma, Non-Hodgkin
- Lymphoma, Non Hodgkin
- Lymphoma, Atypical Diffuse Small Lymphoid
- Lymphoma, Non-Hodgkin's
- Lymphoma, Non Hodgkin's
- Lymphoma, Non-Hodgkin, Familial
- Lymphoma, Non-Hodgkins
- Lymphoma, Non Hodgkins
- Non-Hodgkins Lymphoma
- Small Cleaved-Cell Lymphoma, Diffuse
- Small Cleaved Cell Lymphoma, Diffuse
- Lymphoma, Nonhodgkins
- Nonhodgkins Lymphoma
- Lymphoma, Small Cleaved Cell, Diffuse
- Lymphoma, Small Cleaved-Cell, Diffuse
- Non-Hodgkin Lymphoma
- Non Hodgkin Lymphoma
- Non-Hodgkin's Lymphoma
- Non Hodgkin's Lymphoma
- Diffuse Small Cleaved-Cell Lymphoma
- Diffuse Small Cleaved Cell Lymphoma
- Lymphoma, Nonhodgkin's
- Lymphoma, Nonhodgkin
- Nonhodgkin's Lymphoma
Lymphoma, High-Grade- Lymphoma, High-Grade
- High-Grade Lymphoma
- High-Grade Lymphomas
- Lymphoma, High Grade
- Lymphomas, High-Grade
Lymphoma, Intermediate-Grade- Lymphoma, Intermediate-Grade
- Intermediate-Grade Lymphoma
- Intermediate-Grade Lymphomas
- Lymphoma, Intermediate Grade
- Lymphomas, Intermediate-Grade
Reticulum-Cell Sarcoma- Reticulum-Cell Sarcoma
- Reticulum-Cell Sarcomas
- Sarcomas, Reticulum-Cell
- Reticulum Cell Sarcoma
- Reticulosarcoma
- Reticulosarcomas
- Sarcoma, Reticulum-Cell
- Sarcoma, Reticulum Cell
Lymphoma, Mixed-Cell- Lymphoma, Mixed-Cell
- Lymphoma, Mixed Cell
- Lymphoma, Mixed Lymphocytic-Histiocytic
- Lymphocytic-Histiocytic Lymphoma, Mixed
- Lymphocytic-Histiocytic Lymphomas, Mixed
- Lymphoma, Mixed Lymphocytic Histiocytic
- Lymphomas, Mixed Lymphocytic-Histiocytic
- Mixed Lymphocytic-Histiocytic Lymphoma
- Mixed Lymphocytic-Histiocytic Lymphomas
- Mixed-Cell Lymphoma
- Lymphomas, Mixed-Cell
- Mixed Cell Lymphoma
- Mixed-Cell Lymphomas
- Lymphoma, Mixed
- Lymphomas, Mixed
- Mixed Lymphoma
- Mixed Lymphomas
Lymphoma, Mixed-Cell, Diffuse- Lymphoma, Mixed-Cell, Diffuse
- Diffuse Mixed-Cell Lymphoma
- Diffuse Mixed Cell Lymphoma
- Diffuse Mixed-Cell Lymphomas
- Lymphoma, Diffuse Mixed-Cell
- Lymphomas, Diffuse Mixed-Cell
- Mixed-Cell Lymphomas, Diffuse
- Lymphoma, Diffuse, Mixed Lymphocytic-Histiocytic
- Mixed-Cell Lymphoma, Diffuse
- Mixed Cell Lymphoma, Diffuse
- Lymphoma, Mixed Small and Large Cell, Diffuse
- Lymphoma, Small and Large Cleaved-Cell, Diffuse
- Mixed Small and Large Cell Lymphoma, Diffuse
- Diffuse Mixed Small and Large Cell Lymphoma
- Lymphoma, Mixed Cell, Diffuse
Lymphoma, Small Noncleaved-Cell- Lymphoma, Small Noncleaved-Cell
- Lymphoma, Small Noncleaved Cell
- Small Non-Cleaved-Cell Lymphoma
- Small Non Cleaved Cell Lymphoma
- Lymphoma, Small Non-Cleaved-Cell
- Lymphoma, Small Non Cleaved Cell
- Lymphomas, Small Non-Cleaved-Cell
- Non-Cleaved-Cell Lymphoma, Small
- Non-Cleaved-Cell Lymphomas, Small
- Small Non-Cleaved-Cell Lymphomas
- Diffuse Undifferentiated Lymphoma
- Diffuse Undifferentiated Lymphomas
- Lymphoma, Diffuse Undifferentiated
- Lymphomas, Diffuse Undifferentiated
- Undifferentiated Lymphoma, Diffuse
- Undifferentiated Lymphomas, Diffuse
- Lymphoma, Undifferentiated, Diffuse
- Small Noncleaved-Cell Lymphoma
- Lymphomas, Small Noncleaved-Cell
- Noncleaved-Cell Lymphoma, Small
- Noncleaved-Cell Lymphomas, Small
- Small Noncleaved Cell Lymphoma
- Small Noncleaved-Cell Lymphomas
Lymphoma, Undifferentiated- Lymphoma, Undifferentiated
- Undifferentiated Lymphoma
- Lymphomas, Undifferentiated
- Undifferentiated Lymphomas
- Lymphoma, Pleomorphic
- Lymphomas, Pleomorphic
- Pleomorphic Lymphoma
- Pleomorphic Lymphomas
Lymphoma, Diffuse- Lymphoma, Diffuse
- Diffuse Lymphoma
- Diffuse Lymphomas
- Lymphomas, Diffuse
- Lymphosarcoma
- Lymphosarcomas
- Sarcoma, Lymphatic
- Lymphatic Sarcoma
- Lymphatic Sarcomas
- Sarcomas, Lymphatic
Lymphoma, Low-Grade- Lymphoma, Low-Grade
- Low-Grade Lymphoma
- Low-Grade Lymphomas
- Lymphoma, Low Grade
- Lymphomas, Low-Grade
|
Below are MeSH descriptors whose meaning is more general than "Lymphoma, Non-Hodgkin".
Below are MeSH descriptors whose meaning is more specific than "Lymphoma, Non-Hodgkin".
This graph shows the total number of publications written about "Lymphoma, Non-Hodgkin" by people in this website by year, and whether "Lymphoma, Non-Hodgkin" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1990 | 2 | 0 | 2 | 1992 | 1 | 0 | 1 | 1996 | 1 | 2 | 3 | 1997 | 2 | 1 | 3 | 2000 | 0 | 1 | 1 | 2001 | 1 | 0 | 1 | 2002 | 0 | 1 | 1 | 2003 | 4 | 0 | 4 | 2004 | 2 | 0 | 2 | 2005 | 3 | 0 | 3 | 2006 | 1 | 0 | 1 | 2008 | 0 | 1 | 1 | 2010 | 1 | 1 | 2 | 2011 | 1 | 0 | 1 | 2013 | 1 | 0 | 1 | 2015 | 2 | 0 | 2 | 2016 | 2 | 0 | 2 | 2017 | 2 | 0 | 2 | 2018 | 1 | 0 | 1 | 2019 | 2 | 0 | 2 | 2020 | 2 | 0 | 2 | 2021 | 1 | 0 | 1 | 2022 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Lymphoma, Non-Hodgkin" by people in Profiles.
-
Roy I, Smilnak G, Burkart M, Hamilton E, Thorp K, Miyata S, Ma S, Pro B, Winter J, Gordon L, Karmali R. Cachexia is a risk factor for negative clinical and functional outcomes in patients receiving chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma. Br J Haematol. 2022 04; 197(1):71-75.
-
Scordo M, Wang TP, Ahn KW, Chen Y, Ahmed S, Awan FT, Beitinjaneh A, Chen A, Chow VA, Dholaria B, Epperla N, Farooq U, Ghosh N, Grover N, Hamad N, Hildebrandt GC, Holmberg L, Hong S, Inwards DJ, Jimenez-Jimenez A, Karmali R, Kenkre VP, Khimani F, Klyuchnikov E, Krem MM, Munshi PN, Nieto Y, Prestidge T, Ramakrishnan Geethakumari P, Rezvani AR, Riedell PA, Seo S, Shah NN, Solh M, Yared JA, Kharfan-Dabaja MA, Herrera A, Hamadani M, Sauter CS. Outcomes Associated With Thiotepa-Based Conditioning in Patients With Primary Central Nervous System Lymphoma After Autologous Hematopoietic Cell Transplant. JAMA Oncol. 2021 Jul 01; 7(7):993-1003.
-
Carreau NA, Armand P, Merryman RW, Advani RH, Spinner MA, Herrera AF, Ramchandren R, Hamid MS, Assouline S, Santiago R, Wagner-Johnston N, Paul S, Svoboda J, Bair SM, Barta SK, Nathan S, Karmali R, Torka P, David K, Lansigan F, Persky D, Godfrey J, Chavez JC, Xia Y, Diefenbach C. Checkpoint blockade treatment sensitises relapsed/refractory non-Hodgkin lymphoma to subsequent therapy. Br J Haematol. 2020 10; 191(1):44-51.
-
Hamadani M, Khanal M, Ahn KW, Litovich C, Chow VA, Eghtedar A, Karmali R, Winter A, Fenske TS, Sauter C, Kharfan-Dabaja MA, Awan FT. Higher Total Body Irradiation Dose Intensity in Fludarabine/TBI-Based Reduced-Intensity Conditioning Regimen Is Associated with Inferior Survival in Non-Hodgkin Lymphoma Patients Undergoing Allogeneic Transplantation. Biol Blood Marrow Transplant. 2020 06; 26(6):1099-1105.
-
Shah NN, Ahn KW, Litovich C, Sureda A, Kharfan-Dabaja MA, Awan FT, Ganguly S, Gergis U, Inwards D, Karmali R, Lazaryan A, Lekakis L, Munshi P, Nathan S, Saad AA, Solh M, Steinberg A, Vij R, Wood WA, Fenske TS, Smith S, Hamadani M. Allogeneic transplantation in elderly patients =65 years with non-Hodgkin lymphoma: a time-trend analysis. Blood Cancer J. 2019 12 03; 9(12):97.
-
Burkart M, Schieber M, Basu S, Shah P, Venugopal P, Borgia JA, Gordon L, Karmali R. Evaluation of the impact of cachexia on clinical outcomes in aggressive lymphoma. Br J Haematol. 2019 07; 186(1):45-53.
-
Kanis MJ, Zielenbach M, Karmali R, Peevey J, Blanco LZ, Horowitz JM, Lurain JR. Painless Vulvar Masses as Initial Manifestation of Marginal Zone Lymphoma. J Low Genit Tract Dis. 2018 Jan; 22(1):82-84.
-
Kamel JG, Amber KT. Second primary cutaneous T-cell lymphoma in patients with non-Hodgkin lymphoma: a chicken-or-the-egg issue. Int J Dermatol. 2018 01; 57(1):113.
-
Karmali R, Alrifai T, Fughhi IAM, Ng R, Chukkapalli V, Shah P, Basu S, Nathan S, Szymanski-Grant K, Gordon LI, Venugopal P, Penedo FJ, Borgia JA. Impact of cachexia on outcomes in aggressive lymphomas. Ann Hematol. 2017 Jun; 96(6):951-956.
-
Alrifai T, Grant Szymanski K, Venugopal P, Mahon B, Okwuosa T, Karmali R. Bendamustine and Rituximab: Complete Response in a 62-Year-Old Female with an Aggressive Lymphoma and an Ejection Fraction of 20. Chemotherapy. 2017; 62(2):140-146.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|